Zai Lab Appoints Michel Vounatsos To Its Board of Directors
SHANGHAI and CAMBRIDGE, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that Michel Vounatsos has been appointed to its Board of Directors, effective January 7, 2023.
- SHANGHAI and CAMBRIDGE, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that Michel Vounatsos has been appointed to its Board of Directors, effective January 7, 2023.
- Mr. Vounatsos brings to the Board extensive global leadership and management experience in the biopharmaceutical industry, including more than 25 years of service at leading companies.
- “We are delighted to welcome Michel Vounatsos to the Zai Lab Board of Directors,” said Dr. Samantha Du, Founder, Chairperson, and CEO of Zai Lab.
- In particular, his deep development and commercial experience in neuroscience will significantly benefit the Company as we continue to enhance our expertise in this key therapeutic area.”
“I’m thrilled to be joining the Zai Lab Board of Directors at such a pivotal time in the company’s growth,” said Michel Vounatsos.